Active Ingredient
tulathromycin
Description
Increxxa (tulathromycin injection) indications include:
Beef and Non-Lactating Dairy Cattle
Increxxa is indicated for the treatment of BRD and control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasturella multocida, Histophilus somni and Mycobacterium bovis in beef and non-lactating dairy cattle. It is also approved for treatment of infectious bovine keratoconjunctivitis (IBK) associated with Mycobacterium bovis and treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Suckling Calves, Dairy Calves, and Veal Calves
Increxxa is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasturella multocida, Histophilus somni and Mycobacterium bovis in suckling calves, dairy calves, and veal calves.
Swine
Increxxa is indicated for the treatment of swine respiratory disease (SRD), associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
See package insert for complete product details.
